The Combination of Resveratrol and Quercetin Attenuates Metabolic Syndrome in Rats by Modifying the Serum Fatty Acid Composition and by Upregulating SIRT 1 and SIRT 2 Expression in White Adipose Tissue

Evidence-based Complementary and Alternative Medicine

Volumn 2015, Issue , 2015, Pages

  Peredo Escárcega, Ana Elena ^a   Guarner Lans, Verónica ^a   Pérez Torres, Israel ^a   Ortega Ocampo, Sergio ^a   Carreón Torres, Elizabeth ^a   Castrejón Tellez, Vicente ^a   Díaz Díaz, Eulises ^b   Rubio Ruiz, María Esther ^a  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^b INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; DRINKING WATER; FATTY ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEPTIN; MONOUNSATURATED FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; POLYUNSATURATED FATTY ACID; QUERCETIN; RESVERATROL; SIRTUIN 1; SIRTUIN 2; SIRTUIN 3; SUCROSE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY MASS; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; LIPID COMPOSITION; MALE; METABOLIC SYNDROME X; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING; WHITE ADIPOSE TISSUE;

EID: 84947460135     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2015/474032     Document Type: Article

References (39)

1. M. E. Rubio-Ruiz, M. ElHafidi, I. Pérez-Torres, G. Banos, and V. Guarner, "Medicinal agents and metabolic syndrome," Current Medicinal Chemistry, vol. 20, no. 21, pp. 2626-2640, 2013.
2. M. El Hafidi, R. Valdez, and G. Baños, "Possible relationship between altered fatty acid composition of serum, platelets, and aorta and hypertension induced by sugar feeding in rats," Clinical & Experimental Hypertension, vol. 22, no. 1, pp. 99-108, 2000.
3. A. Ruiz-Ramírez, M. Chávez-Salgado, J. A. Peñeda-Flores, E. Zapata, F. Masso, and M. El-Hafidi, "High-sucrose diet increases ROS generation, FFA accumulation, UCP2 level, and proton leak in liver mitochondria," American Journal of Physiology: Endocrinology and Metabolism, vol. 301, no. 6, pp. E1198-E1207, 2011.
4. I. Pérez-Torres, A. Zúñiga Muñoz, U. Beltrán-Rodríguez, E. Díaz-Díaz, R. Martínez-Memije, and V. G. Lans, "Modification of the liver fatty acids by Hibiscus sabdariffa Linnaeus (Malvaceae) infusion, its possible effect on vascular reactivity in a metabolic syndrome model," Clinical and Experimental Hypertension, vol. 36, no. 3, pp. 123-131, 2014.
5. S. El Akoum, V. Lamontagne, I. Cloutier, and J.-F. Tanguay, "Nature of fatty acids in high fat diets differentially delineates obesity-linked metabolic syndrome components in male and female C57BL/6J mice," Diabetology & Metabolic Syndrome, vol. 3, article 34, 2011.
6. P. Fischer-Posovszky, V. Kukulus, D. Tews et al., "Resveratrol regulates human adipocyte number and function in a Sirt1-dependent manner," The American Journal of Clinical Nutrition, vol. 92, no. 1, pp. 5-15, 2010.
7. S. Vidyashankar, R. S. Varma, and P. S. Patki, "Quercetin ameliorate insulin resistance and up-regulates cellular antioxidants during oleic acid induced hepatic steatosis in HepG2 cells," Toxicology in Vitro, vol. 27, no. 2, pp. 945-953, 2013.
8. V. Guarner and M. E. Rubio-Ruiz, "Aging, metabolic syndrome and the heart," Aging and Disease, vol. 3, no. 3, pp. 269-279, 2012.
9. J. C. Newman, W. He, and E. Verdin, "Mitochondrial protein acylation and intermediary metabolism: regulation by sirtuins and implications for metabolic disease," Journal of Biological Chemistry, vol. 287, no. 51, pp. 42436-42443, 2012.
10. I. Eseberri, J. Miranda, A. Lasa, I. Churruca, and M. P. Portillo, "Doses of quercetin in the range of serum concentrations exert delipidating effects in 3T3-L1 preadipocytes by acting on different stages of adipogenesis, but not in mature adipocytes," Oxidative Medicine and Cellular Longevity, vol. 2015, Article ID 480943, 11 pages, 2015.
11. N. Arias, M. T. Macarulla, L. Aguirre, I. Milton, and M. P. Portillo, "The combination of resveratrol and quercetin enhances the individual effects of these molecules on triacylglycerol metabolism in white adipose tissue," European Journal of Nutrition, 2015.
12. M. E. Rubio, G. Baños, E. Díaz, and V. Guarner, "Effect of age on insulin-induced endothelin release and vasoreactivity in hypertriglyceridemic and hypertensive rats," Experimental Gerontology, vol. 41, no. 3, pp. 282-288, 2006.
13. Ó. Pérez Méndez and L. García Hernández, "High-Density Lipoproteins (HDL) size and composition are modified in the rat by a diet supplemented with 'Hass' avocado (Persea americana Miller)," Archivos de Cardiologia de Mexico, vol. 77, no. 1, pp. 17-24, 2007.
14. M. E. Rubio-Ruíz, L. Del Valle-Mondragón, V. Castrejón-Tellez, E. Carreón-Torres, E. Díaz-Díaz, and V. Guarner-Lans, "Angiotensin II and 1-7 during aging in metabolic syndrome rats. Expression of AT1, AT2 and Mas receptors in abdominal white adipose tissue," Peptides, vol. 57, pp. 101-108, 2014.
15. M. M. Bradford, "A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding," Analytical Biochemistry, vol. 72, no. 1-2, pp. 248-254, 1976.
16. G. Alberdi, V. M. Rodríguez, J. Miranda et al., "Changes in white adipose tissuemetabolism induced by resveratrol in rats," Nutrition and Metabolism, vol. 8, article 29, 2011.
17. Y. Yamamoto and E. Oue, "Antihypertensive effect of quercetin in rats fedwith a high-fat high-sucrose diet," Bioscience, Biotechnology and Biochemistry, vol. 70, no. 4, pp. 933-939, 2006.
18. L. Rivera, R. Morón, A. Zarzuelo, and M. Galisteo, "Longtermresveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats," Biochemical Pharmacology, vol. 77, no. 6, pp. 1053-1063, 2009.
19. S. K. Panchal, H. Poudyal, and L. Brown, "Quercetin ameliorates cardiovascular, hepatic, and metabolic changes in diet-induced metabolic syndrome in rats," Journal of Nutrition, vol. 142, no. 6, pp. 1026-1032, 2012.
20. H. Ghanim, C. L. Sia, S. Abuaysheh et al., "An antiinflammatory and reactive oxygen species suppressive effects of an extract of Polygonum cuspidatum containing resveratrol," Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 9, pp.E1-E8, 2010.
21. J. Yoshino, C. Conte, L. Fontana et al., "Resveratrol supplementation does not improve metabolic function in non-obese women with normal glucose tolerance," Cell Metabolism, vol. 16, no. 5, pp. 658-664, 2012.
22. M. T. Macarulla, G. Alberdi, S. Gómez et al., "Effects of different doses of resveratrol on body fat and serum parameters in rats fed a hypercaloric diet," Journal of Physiology and Biochemistry, vol. 65, no. 4, pp. 369-376, 2009.
23. M. Rodriguez-Cruz, A. R. Tovar, B. Palacios-González, M. Del Prado, and N. Torres, "Synthesis of long-chain polyunsaturated fatty acids in lactating mammary gland: role of Δ5 and Δ6 desaturases, SREBP-1, PPARα, and PGC-1," The Journal of Lipid Research, vol. 47, no. 3, pp. 553-560, 2006.
24. L. Madsen, R. K. Petersen, and K. Kristiansen, "Regulation of adipocyte differentiation and function by polyunsaturated fatty acids," Biochimica et Biophysica Acta, vol. 1740, no. 2, pp. 266-286, 2005.
25. J. J. Moreno, "Resveratrol modulates arachidonic acid release, prostaglandin synthesis, and 3T6 fibroblast growth," Journal of Pharmacology and Experimental Therapeutics, vol. 294, no. 1, pp. 333-338, 2000.
26. F. A. Elbarbry, A. Vermehren-, and D. Rao, "Modulation of arachidonic acid metabolism in the rat kidney by resveratrol: implications for regulation of blood pressure, " Pharmacologia, vol. 6, no. 8, pp. 360-370, 2015.
27. C. A. Cotrim, S. C. B. de Oliveira, E. B. S. Diz Filho et al., "Quercetin as an inhibitor of snake venom secretory phospholipase A2," Chemico-Biological Interactions, vol. 189, no. 1-2, pp. 9-16, 2011.
28. S. Keser, O. Yilmaz, and M. Tuzcu, "Effects of resveratrol on fatty acid levels in serum and erythrocytes of rats administered potassium bromate," Asian Journal of Chemistry, vol. 22, no. 10, pp. 7841-7849, 2010.
29. E. Phielix, T. Jelenik, P. Nowotny, J. Szendroedi, and M. Roden, "Reduction of non-esterified fatty acids improves insulin sensitivity and lowers oxidative stress, but fails to restore oxidative capacity in type 2 diabetes: a randomised clinical trial," Diabetologia, vol. 57, no. 3, pp. 572-581, 2014.
30. S. Gómez-Zorita, A. Fernández-Quintela, M. T. MacArulla et al., "Resveratrol attenuates steatosis in obese Zucker rats by decreasing fatty acid availability and reducing oxidative stress," British Journal of Nutrition, vol. 107, no. 2, pp. 202-210, 2012.
31. S. Wein and S. Wolffram, "Concomitant intake of quercetin with a grain-based diet acutely lowers postprandial plasma glucose and lipid concentrations in pigs," BioMed Research International, vol. 2014, Article ID 748742, 6 pages, 2014.
32. X. Li, "SIRT1 and energy metabolism," Acta Biochimica et Biophysica Sinica, vol. 45, no. 1, pp. 51-60, 2013.
33. J. Dong, X. Zhang, L. Zhang et al., "Quercetin reduces obesityassociated ATMinfiltration and inflammation in mice: amechanism including AMPKα1/SIRT," The Journal of Lipid Research, vol. 55, no. 3, pp. 363-374, 2014.
34. Z. E. Floyd, Z. Q. Wang, G. Kilroy, and W. T. Cefalu, "Modulation of peroxisome proliferator-activated receptor γ stability and transcriptional activity in adipocytes by resveratrol," Metabolism, vol. 57, no. 7, supplement 1, pp. S32-S38, 2008.
35. C. D. S. Costa, F. Rohden, T. O. Hammes et al., "Resveratrol upregulated SIRT1, FOXO1, and adiponectin and downregulated PPARγ1-3 mRNA expression in human visceral adipocytes," Obesity Surgery, vol. 21, no. 3, pp. 356-361, 2011.
36. G. Kelly, "Areviewof the sirtuin system, its clinical implications, and the potential role of dietary activators like resveratrol: part 1," Alternative Medicine Review, vol. 15, no. 3, pp. 245-263, 2010.
37. S. Gregory, "A review of the sirtuin system, its clinical implications, and thepotential role of dietary activators like resveratrol. Part 2," Alternative Medicine Review, vol. 15, no. 4, pp. 313-328, 2010.
38. S. A. Newsom, K. E. Boyle, and J. E. Friedman, "Sirtuin 3: a major control point for obesity-related metabolic diseases?" Drug Discovery Today: Disease Mechanisms, vol. 10, no. 1-2, pp. e35-e40, 2013.
39. T. Shi, F. Wang, E. Stieren, and Q. Tong, "SIRT3, a mitochondrial sirtuin deacetylase, regulates mitochondrial function and thermogenesis in brown adipocytes," Journal of Biological Chemistry, vol. 280, no. 14, pp. 13560-13567, 2005.